Reuters logo
BRIEF-Sarepta Therapeutics says exercise of option to purchase additional convertible senior notes due 2024
November 10, 2017 / 8:28 AM / 13 days ago

BRIEF-Sarepta Therapeutics says exercise of option to purchase additional convertible senior notes due 2024

Nov 10 (Reuters) - Sarepta Therapeutics Inc -

* SAREPTA THERAPEUTICS ANNOUNCES EXERCISE OF INITIAL PURCHASERS’ OPTION TO PURCHASE ADDITIONAL CONVERTIBLE SENIOR NOTES DUE 2024 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below